HomeNewsBusinessEconomyADB expects India's economic growth to slow down to 4% in FY21 on global pandemic
Trending Topics

ADB expects India's economic growth to slow down to 4% in FY21 on global pandemic

Growth in India will remain subdued after the country suffered a sharp slowdown last year, from 6.1 percent in fiscal 2019 to 5 percent, as a credit crunch that originated in the non-banking financial sector severely hampered bank lending , the Manila-based lender said.

April 03, 2020 / 09:18 IST
Story continues below Advertisement

India's economic growth is likely to slow down to 4 percent this fiscal on the back of the current global health emergency, Asian Development Bank said in its outlook for FY21 on April 3.

Growth in India will remain subdued after the country suffered a sharp slowdown last year, from 6.1 percent in fiscal 2019 to 5 percent, as a credit crunch that originated in the non-banking financial sector severely hampered bank lending , the Manila-based lender said.

Story continues below Advertisement

"We face extraordinarily challenging times. The outbreak of coronavirus (COVID-19) is disrupting people's lives and interrupting business and other economic activities around the world," said Masatsugu Asakawa, President of Asian Development Bank.

Noting that COVID-19 has not yet spread extensively in India, ADB said measures to contain the virus and a weaker global environment will whip up headwinds, offsetting support from corporate and personal income tax cuts as well as financial sector reforms which are meant to revive credit flows.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show